SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-016753
Filing Date
2023-03-07
Accepted
2023-03-07 16:30:38
Documents
2
Period of Report
2023-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 13721
2 POA DOCUMENT poa.txt EX-24 2763
  Complete submission text file 0001209191-23-016753.txt   17910
Mailing Address 3303 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address
Taylor Daphne (Reporting) CIK: 0001393549 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37746 | Film No.: 23713019

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations